CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of genetic diseases
3.4.1.2. Increase in prevalence of cancer
3.4.1.3. Rise in the number of genetic testing.
3.4.2. Restraints
3.4.2.1. High cost of genetic testing
3.4.3. Opportunities
3.4.3.1. Increase in number of adoptions of key strategies.
CHAPTER 4: GENETIC TESTING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Predictive and Presymptomatic Testing
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Carrier Testing
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Prenatal and Newborn Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Diagnostic Testing
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Pharmacogenomic Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
CHAPTER 5: GENETIC TESTING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Cytogenetic testing
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Biochemical testing
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Molecular testing
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: GENETIC TESTING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Cancer diagnosis
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Genetic disease diagnosis
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: GENETIC TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by Application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Technology
7.2.5.1.3. Market size and forecast, by Application
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Technology
7.2.5.2.3. Market size and forecast, by Application
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Technology
7.2.5.3.3. Market size and forecast, by Application
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by Application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Technology
7.3.5.1.3. Market size and forecast, by Application
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Technology
7.3.5.2.3. Market size and forecast, by Application
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Technology
7.3.5.3.3. Market size and forecast, by Application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Technology
7.3.5.4.3. Market size and forecast, by Application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Technology
7.3.5.5.3. Market size and forecast, by Application
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Technology
7.3.5.6.3. Market size and forecast, by Application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by Application
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Technology
7.4.5.1.3. Market size and forecast, by Application
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Technology
7.4.5.2.3. Market size and forecast, by Application
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Technology
7.4.5.3.3. Market size and forecast, by Application
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Technology
7.4.5.4.3. Market size and forecast, by Application
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Technology
7.4.5.5.3. Market size and forecast, by Application
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Technology
7.4.5.6.3. Market size and forecast, by Application
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by Application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Technology
7.5.5.1.3. Market size and forecast, by Application
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Technology
7.5.5.2.3. Market size and forecast, by Application
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Technology
7.5.5.3.3. Market size and forecast, by Application
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Technology
7.5.5.4.3. Market size and forecast, by Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Bio-Rad Laboratories, Inc.
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Myriad Genetics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Danaher Corporation
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. F. Hoffmann-La Roche Ltd.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Illumina, Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Qiagen N.V
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. CSL Limited
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Luminex Corporation
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
TABLE 01. GLOBAL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 09. GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 16. GENETIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 23. U.S. GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. CANADA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 26. CANADA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MEXICO GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 29. MEXICO GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 32. EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. EUROPE GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 34. GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. GERMANY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 36. GERMANY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. FRANCE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 39. FRANCE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. UK GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. UK GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 42. UK GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. ITALY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 45. ITALY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. SPAIN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 48. SPAIN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 51. REST OF EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 56. JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. JAPAN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 58. JAPAN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. CHINA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 61. CHINA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. INDIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 64. INDIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 67. AUSTRALIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 70. SOUTH KOREA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 76. LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. LAMEA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. BRAZIL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 90. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 91. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 92. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 93. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 94. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 95. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 96. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 97. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 98. MYRIAD GENETICS, INC.: KEY EXECUTIVES
TABLE 99. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
TABLE 100. MYRIAD GENETICS, INC.: SERVICE SEGMENTS
TABLE 101. MYRIAD GENETICS, INC.: PRODUCT PORTFOLIO
TABLE 102. MYRIAD GENETICS, INC.: KEY STRATERGIES
TABLE 103. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 104. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 105. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 106. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 107. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 108. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 110. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 111. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 112. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 113. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 114. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 115. ILLUMINA, INC.: KEY STRATERGIES
TABLE 116. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 117. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 118. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
TABLE 119. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 120. QIAGEN N.V: KEY EXECUTIVES
TABLE 121. QIAGEN N.V: COMPANY SNAPSHOT
TABLE 122. QIAGEN N.V: PRODUCT SEGMENTS
TABLE 123. QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 124. CSL LIMITED: KEY EXECUTIVES
TABLE 125. CSL LIMITED: COMPANY SNAPSHOT
TABLE 126. CSL LIMITED: PRODUCT SEGMENTS
TABLE 127. CSL LIMITED: PRODUCT PORTFOLIO
TABLE 128. LUMINEX CORPORATION: KEY EXECUTIVES
TABLE 129. LUMINEX CORPORATION: COMPANY SNAPSHOT
TABLE 130. LUMINEX CORPORATION: PRODUCT SEGMENTS
TABLE 131. LUMINEX CORPORATION: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
